ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EROX ETF

310.10
1.60 (0.52%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
ETF BIT:EROX Italy Exchange Traded Fund
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  1.60 0.52% 310.10 309.15 310.40 310.15 309.95 309.95 75 16:37:18

Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand

12/09/2007 7:07pm

PR Newswire (US)


ETF (BIT:EROX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more ETF Charts.
SAN JOSE, Calif., Sept. 12 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC:EROX) (BULLETIN BOARD: EROX) ("HPS" or "the Company") today announced the signing of an exclusive Agency Agreement with Brand Intelligence Group, Inc. ("BIG"), to reposition and promote the Company's Natural Attraction(R) brand, which contains its proprietary and patented human pheromone technology. Under the terms of the Agreement, HPS and BIG will work together to develop a comprehensive program to repackage, reposition and promote the Natural Attraction brand, in order to capitalize on the potential strength of the trademark and its underlying technology. In commenting on the Agreement, an HPS spokesperson indicated that the Company has been primarily focused on developing long-term relationships with leaders in the consumer products arena to incorporate the Company's mood-enhancing technology in products marketed and sold by such corporate partners. "While our primary focus has been successful in attracting industry leaders to incorporate our technology in their products, we have not focused our Natural Attraction line," said Bill Horgan, CEO, of the Company. In August of last year, the Company entered into a License Agreement with a Johnson & Johnson subsidiary, and most recently signed a non-exclusive agreement with Schwarkf and Henkel for several hair care lines. The Company noted that additional product introductions by Licensees are imminent. BIG is a New York City-based consortium of branding, communication, licensing and marketing firms specializing in fragrance, fashion, lifestyle and luxury products. Co-presidents, Louis Iacovelli and Deborah Moses, are recognized experts in positioning and repositioning brands. Their collective client experience in beauty and fragrance include L'Oreal, Estee Lauder, Givenchy Fragrance, Coty Prestige, Dolce & Gabbana, Vera Wang, Gianni Versace, Yves Saint Laurent, Moschino, Joseph Abboud, Smash Box, Urban Decay, Bare Escentuals and Be Fine. Human Pheromone Sciences, Inc. is a technology-based company, whose proof-of concept products included prestige-priced fragrances and toiletries and environmental products sold under the Natural Attraction(R), REALM(R), innerREALM(R) and EROX(R) trademarks. These products contain mood-enhancing compounds, whose efficacy has been validated at leading universities around the world, and whose use is covered under United States and foreign patents. The Company is also involved in research and product development efforts on new compounds that have been previously identified as stimulating the emotional centers of the human brain. Further information is available on line at http://www.erox.com/. The statements in this news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10-KSB for the year ended December 31, 2006, and Form 10-QSB for the quarters ended March 31, 2007 and June 30, 2007, as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. DATASOURCE: Human Pheromone Sciences, Inc. CONTACT: William P. Horgan, Chairman, CEO of Human Pheromone Sciences, Inc., +1-408-938-3030 Web site: http://www.erox.com/

Copyright

1 Year ETF Chart

1 Year ETF Chart

1 Month ETF Chart

1 Month ETF Chart

Your Recent History

Delayed Upgrade Clock